Drug recall · June 13, 2018
Naloxone Hydrochloride Injection recall
Why: Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and 10 count box (NDC 0409-1782-69), Rx Only, Hospira Inc., Lake Forest, IL
- Lots / codes
72680LL, Exp. 1DEC2018 (NDC 0409-1782-03); 76510LL, Exp. 1APR2019 (NDC 0409-1782-69)
- Quantity
- 164,860 syringes
- Company
- Hospira Inc, Lake Forest, Lake Forest, IL
- Distribution
- Nationwide in the U.S., Puerto Rico, and Guam
- Initiated
- June 4, 2018 · Voluntary: Firm initiated
- Classified
- July 2, 2018
- Reported
- June 13, 2018
- Ended
- March 27, 2020
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Naloxone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.